Novel treatments for chronic lymphocytic leukemia and moving forward

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting

Volumn , Issue , 2014, Pages e317-e325

  Brown, Jennifer R ^a   Porter, David L ^a   O'Brien, Susan M ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4-(4-((2-(4-CHLOROPHENYL)-4,4-DIMETHYLCYCLOHEX-1-EN-1-YL)METHYL)PIPERAZIN-1-YL)-N-((3-NITRO-4-((TETRAHYDRO-2H-PYRAN-4-YLMETHYL)AMINO)PHENYL)SULFONYL)-2-(1H-PYRROLO(2,3-B)PYRIDIN-5-YLOXY)BENZAMIDE; AGAMMAGLOBULINAEMIA TYROSINE KINASE; ANTINEOPLASTIC AGENT; CD19 ANTIGEN; CYCLOPHOSPHAMIDE; FLUDARABINE; FUSED HETEROCYCLIC RINGS; IBRUTINIB; IDELALISIB; IPI-145; ISOQUINOLINE DERIVATIVE; MOLECULAR LIBRARY; MONOCLONAL ANTIBODY; OBINUTUZUMAB; PROTEIN BCL 2; PROTEIN TYROSINE KINASE; PURINE DERIVATIVE; PYRAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE; QUINAZOLINONE DERIVATIVE; RITUXIMAB; SULFONAMIDE; VIDARABINE;

ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; METABOLISM; MOLECULAR LIBRARY; MOLECULARLY TARGETED THERAPY; PHARMACOLOGY; PROCEDURES;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIGENS, CD19; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BICYCLO COMPOUNDS, HETEROCYCLIC; CYCLOPHOSPHAMIDE; HUMANS; IMMUNOTHERAPY; ISOQUINOLINES; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MOLECULAR TARGETED THERAPY; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; PURINES; PYRAZOLES; PYRIMIDINES; QUINAZOLINONES; RITUXIMAB; SMALL MOLECULE LIBRARIES; SULFONAMIDES; VIDARABINE;

EID: 84964698370     PISSN: None     EISSN: 15488756     Source Type: Journal    
DOI: 10.14694/EdBook_AM.2014.34.e317     Document Type: Review

References (0)